GO Term | Evidence Code | PMID |
---|---|---|
endothelial cell migration | ||
ganglion development | ||
positive regulation of receptor signaling pathway via JAK-STAT | ||
positive regulation of vascular endothelial growth factor production | ||
membrane lipid catabolic process |
GO Term | Evidence Code | PMID |
---|---|---|
intracellular membrane-bounded organelle | ||
endoplasmic reticulum membrane |
|
|
mitochondrion |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
DO ID | Disease Name | Source |
---|---|---|
DOID:13094 | branch retinal artery occlusion | |
DOID:13098 | central retinal artery occlusion | |
DOID:13174 | dissociated nystagmus | |
DOID:1319 | brain cancer | |
DOID:13206 | nodular prostate | |
DOID:13223 | uterine fibroid | |
DOID:1324 | lung cancer | |
DOID:1325 | bronchus cancer | |
DOID:13515 | tuberous sclerosis | |
DOID:13544 | low tension glaucoma |
HPO ID | HPO Term |
---|---|
HP:0000007 | Autosomal recessive inheritance |
HP:0000486 | Strabismus |
HP:0000501 | Glaucoma |
HP:0000505 | Visual impairment |
HP:0000523 | Subcapsular cataract |
HP:0000525 | Abnormality iris morphology |
HP:0000541 | Retinal detachment |
HP:0000557 | Buphthalmos |
HP:0000572 | Visual loss |
HP:0000587 | Abnormal optic nerve morphology |
Disease ID | Disease Name |
---|---|
OMIM:617315 |
|
ORPHA:98976 |
|
OMIM:600975 |
|
ORPHA:98977 |
|
ORPHA:708 |
|
OMIM:231300 |
|
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
102451045 | PELSI12365 | ||
114045358 | VOMUR04613 | ||
113901109 | BOBOX19805 | ||
100949593 | OTOGA07059 | ||
101073188 | TAKRU40005 | ||
102009223 | CHILA10872 | ||
105733181 | AOTNA11768 | ||
110201392 | PHACI33757 | ||
101049264 | SAIBB11553 | ||
101970101 | ICTTR00334 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024